Mirati Therapeutics
MRTX
Rank 1808
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 9393 TOWNE CENTRE DRIVE, SUITE 200, SAN DIEGO, CA, US
Mirati Therapeutics - Key figures
Market cap 3.14 Billion
Revenue 72.09 Million
Profit 72.09 Million
P/E Ratio No information
P/s Ratio 43.49
Mirati Therapeutics - Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops candidate products to address the genetic and immunological promoters of cancer in the United States.
The company is headquartered in San Diego, California.